Showing results (2051-2060 of 2,931) with videos related to

Sort By:
Pageof 294
Biorxiv : the Preprint Server for Biology|August 9, 2020
EUAdb: a resource for COVID-19 test developmentAlyssa Woronik, Henry W Shaffer, Karin Kiontke, et al.
The Journal of Head Trauma Rehabilitation|September 30, 2025
Examining the Sensitivity of the 2023 American Congress of Rehabilitation Medicine's Diagnostic Criteria for Mild Traumatic Brain Injury Using a Sport-Related Concussion SampleAvi N Albert, Anthony E Bishay, Olivia Shaffer, et al.
JCI Insight|August 12, 2021
Altered pattern of circulating miRNAs in HIV lipodystrophy perturbs key adipose differentiation and inflammation pathwaysSuman Srinivasa, Ruben Garcia-Martin, Martin Torriani, et al.
Current Biology : CB|November 14, 2024
Lysosomal damage triggers a p38 MAPK-dependent phosphorylation cascade to promote lysophagy via the small heat shock protein HSP27Elizabeth R Gallagher, Peace T Oloko, Tessa C Fitch, et al.
JSAMS Plus|July 12, 2026
Factors influencing delayed removal from middle school, high school, and collegiate competition following sport-related concussionClayton R Baker, Keen Zoller, Jonathan Bao, et al.
Faraday Discussions|July 28, 2026
NMR spectroscopic investigation of LiNO3-induced SEI modification in Li-S batteries: a concentration-dependent studyJana B Fritzke, Mark Stockham, Marie Juramy, et al.
Obesity (Silver Spring, Md.)|February 3, 2009
Baseline correlates of insulin resistance in inner city high-BMI African-American childrenAarthi Raman, Mark D Fitch, Mark L Hudes, et al.
The Journal of Biological Chemistry|July 18, 2006
AMP-activated kinase inhibits the epithelial Na+ channel through functional regulation of the ubiquitin ligase Nedd4-2Vivek Bhalla, Nicholas M Oyster, Adam C Fitch, et al.
Annals of the New York Academy of Sciences|August 2, 2022
Melodic Intonation Therapy for aphasia: A multi-level meta-analysis of randomized controlled trials and individual participant dataTudor Popescu, Benjamin Stahl, Brenton M Wiernik, et al.
American Journal of Clinical Oncology|March 23, 2011
Cediranib (AZD2171) in patients with advanced hepatocellular carcinoma: a phase II North Central Cancer Treatment Group Clinical TrialSteven Robert Alberts, Tom R Fitch, George P Kim, et al.
Pageof 294